April 8th 2025
The new data builds upon previously reported 6- and 12-month positive results from adult patients treated in the same study.
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
Key factors help clinician assess strabismus, diplopia
August 1st 2004Oklahoma City-When patients with strabismus or diplopia present, ophthalmologists question if the condition is a congenital or an acquired neurologic disease and if imaging or any other tests are needed. R. Michael Siatkowski, MD, differentiated among the various possibilities.
Read More
Weisenfeld Award winner highlights the success behind retinoblasma treatment, survival rate
April 26th 2004One of the few success stories in pediatric oncology, retinoblastomahas ridden scientific and therapeutic advances to a near-100% survival,a 180-degree turnabout from a century ago, said the 2004 recipient of MildredWeisenfeld Award for Excellence in Ophthalmology.
Read More
ARVO 2004 Retina presentations
April 1st 2004Among the 233 sessions dedicated to retina, almost 75 are free papersand symposia sessions. The Editorial Advisory Board of OphthalmologyTimes reviewed the retina abstracts to be presented at this year's meeting.Some of the board's selections are highlighted here.
Read More
Part-, full-time patching equally effective for severe amblyopia
April 1st 2004Rochester, MN-In young children with severe amblyopia, 6 hours of prescribed patching per day appears to be as effective as full-time prescribed patching when both are combined with 1 hour of near activity, according to the recently published results of the Amblyopia Treatment Study of patching regimens for severe amblyopia.
Read More
Research into deprivation amblyopia spawns wealth of information, greater understanding
April 1st 2004Morgantown, WV-Amblyopia due to stimulus deprivation differs from other forms of amblyopia in several ways. Research relating to deprivation amblyopia has resulted in increased understanding of the anatomic changes of amblyopia, guidance for treatment of amblyopia in general, and an improved definition of the concept of a critical period of visual development, said Terry L. Schwartz, MD.
Read More
Used properly, systemic medications effective in uveitis
April 1st 2004Baltimore-The use of systemic medications in uveitis therapy often is associated with superior outcomes, and the best results are likely when physicians adhere to proper dosing techniques and closely monitor patients for side effects, said Douglas A. Jabs, MD, MBA.
Read More
Angiogenesis plays role in ophthalmic diseases
April 1st 2004Editor's Note: Due to the large volume of information presented at the Angiogenesis 2004 meeting, this article is an overview of many of the presentations. Ophthalmology Times will provide greater detail of many of the sessions in upcoming issues.
Read More
Find out what's hot in frames to add to your inventory
March 15th 2004At this time many of you will be attending or about to attend the American Association of Dispensing Ophthalmologists (AADO) 10th Dispensing Ophthalmology Conference March 25 to 28 at International Vision Expo East, New York. Your participation in the largest optical and educational show can be even more beneficial if you take the time to prepare in advance.
Read More
Post-LASIK infection mandates prompt action
March 1st 2004Anaheim, CA-Infection after LASIK is uncommon, but when it happens, the consequences can be devastating, said Eduardo C. Alfonso, MD, at the International Society of Refractive Surgery/American Academy of Ophthalmology subspecialty day meeting.
Read More
Adding an optical dispensary to an existing ophthalmology practice can be a profitable and exciting venture, but one that must be organized carefully and executed deliberately. Ophthalmologists must plan-from the dispensary's inception to construction-exactly where everything will be and how it will appear to their patients.
Read More
Refractive surgery advances mean life-long gains
February 15th 2004Anaheim, CA-Surgeons and patients often consider refractive surgery to be a one-time intervention. A patient may have had RK or LASIK and possibly an enhancement, but then the doctor-patient relationship ended. This is no longer the case, nor should it be, explained George O. Waring III, MD, who delivered the keynote speech on refractive re-treatments during the International Society of Refractive Surgery/American Academy of Ophthalmology subspecialty day meeting.
Read More
Description of hay fever dates to as early as mid-1500s
February 15th 2004Editor's Note: In 1896 Alexander Duane, MD, author of the Student's Medical Dictionary, defined hay fever, otherwise known as hay asthma, as "a violent acute inflammation or congestion of the conjunctiva, nasal and bronchial mucous membranes, recurring at about the same time every spring or summer in those predisposed to it. It is apparently caused by inhalation of the pollen of certain plants and relieved by migration to a locality where the pollen is not found." This definition is concise and still valid today. The history of ocular allergy, and hay fever in particular, is rich and interesting, with astute
Read More
Lens designers and manufacturers are constantly searching for the perfect progressive addition lens. They strive to design the most comfortable lens both optically and cosmetically. This combination of both equals a lens that is thin, light, and versatile for all lifestyle activities, while delivering the sharpest visual acuity possible without noticeable power shifts in every meridian. Ophthalmic professionals don't have to wait for tomorrow for this technologically advanced progressive lens. It's here today.
Read More
Educational materials offered for patients, staff
December 15th 2003Jacksonville, FL-VISTAKON, a division of Johnson & Johnson Vision Care Inc., is offering an array of educational materials to help eye-care professionals instruct patients about eye health and run their practices more efficiently.
Read More